P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTION

Development of cardiac resynchronisation therapy (CRT) in recent years became a breakthrough in treatment of severe heart failure. The aim of this study was evaluation of CRT effect on the autonomous nervous system function. Methods: The study covered a group of 55 patients (45 men, 10 women; mean...

Full description

Bibliographic Details
Main Authors: Anna Przybyla*, Danuta Czarnecka
Format: Article
Language:English
Published: Atlantis Press 2015-11-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125930692/view
id doaj-ea64cd62e1324698a02192f4b0874636
record_format Article
spelling doaj-ea64cd62e1324698a02192f4b08746362020-11-25T01:27:45ZengAtlantis PressArtery Research 1876-44012015-11-011210.1016/j.artres.2015.10.333P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTIONAnna Przybyla*Danuta CzarneckaDevelopment of cardiac resynchronisation therapy (CRT) in recent years became a breakthrough in treatment of severe heart failure. The aim of this study was evaluation of CRT effect on the autonomous nervous system function. Methods: The study covered a group of 55 patients (45 men, 10 women; mean age 67.04±9.13 years) with chronic heart failure stable for at least last 3 months, in the NYHA functional class III or IV despite optimal pharmacotherapy, with a reduced left ventricular ejection fraction ≤ 35%, wide QRS complexes ≥ 120 ms, and sinus rhythm present during the examination. Before the resynchronisation system was implanted and after three months of observation arterial baroreflex sensitivity (BRS) was evaluated with the sequence technique, and with the α coefficient and the transfer function. Results: Three months after implantation of the CRT device, a statistically significant increase in the arterial baroreflex sensitivity was observed for all methods used in the study, both when lying and breathing spontaneously (BRSseq: 5,96±2,07 ms/mmHg vs 7,64±4,73 ms/mmHg, p<0,001; αLF: 6,00±4,44 ms/mmHg vs 7,68±5,09 ms/mmHg, p=0,029; αHF: 6,53±3,19 ms/mmHg vs 10,15±6,84 ms/mmHg, p<0,001; TFLF: 3,18±3,05 ms/mmHg vs 4,18±3,17 ms/mmHg, p=0,01; TFHF: 3,54±2,02 ms/mmHg vs 5,72±4,24 ms/mmHg, p<0,001), as well as when lying with breathing controlled. Furthermore, after three months from the CRT implementation, all monitored BRS indicators were significantly reduced in response to orthostatic stimulus. Such modulatory ability was not observed before implantation of the CRT device. Conclusions: The study confirmed the beneficial effect of the CRT on the autonomous nervous system function.https://www.atlantis-press.com/article/125930692/view
collection DOAJ
language English
format Article
sources DOAJ
author Anna Przybyla*
Danuta Czarnecka
spellingShingle Anna Przybyla*
Danuta Czarnecka
P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTION
Artery Research
author_facet Anna Przybyla*
Danuta Czarnecka
author_sort Anna Przybyla*
title P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTION
title_short P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTION
title_full P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTION
title_fullStr P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTION
title_full_unstemmed P8.11 EFFECT OF CARDIAC RESYNCHRONISATION THERAPY ON THE AUTONOMIC NERVOUS SYSTEM FUNCTION
title_sort p8.11 effect of cardiac resynchronisation therapy on the autonomic nervous system function
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2015-11-01
description Development of cardiac resynchronisation therapy (CRT) in recent years became a breakthrough in treatment of severe heart failure. The aim of this study was evaluation of CRT effect on the autonomous nervous system function. Methods: The study covered a group of 55 patients (45 men, 10 women; mean age 67.04±9.13 years) with chronic heart failure stable for at least last 3 months, in the NYHA functional class III or IV despite optimal pharmacotherapy, with a reduced left ventricular ejection fraction ≤ 35%, wide QRS complexes ≥ 120 ms, and sinus rhythm present during the examination. Before the resynchronisation system was implanted and after three months of observation arterial baroreflex sensitivity (BRS) was evaluated with the sequence technique, and with the α coefficient and the transfer function. Results: Three months after implantation of the CRT device, a statistically significant increase in the arterial baroreflex sensitivity was observed for all methods used in the study, both when lying and breathing spontaneously (BRSseq: 5,96±2,07 ms/mmHg vs 7,64±4,73 ms/mmHg, p<0,001; αLF: 6,00±4,44 ms/mmHg vs 7,68±5,09 ms/mmHg, p=0,029; αHF: 6,53±3,19 ms/mmHg vs 10,15±6,84 ms/mmHg, p<0,001; TFLF: 3,18±3,05 ms/mmHg vs 4,18±3,17 ms/mmHg, p=0,01; TFHF: 3,54±2,02 ms/mmHg vs 5,72±4,24 ms/mmHg, p<0,001), as well as when lying with breathing controlled. Furthermore, after three months from the CRT implementation, all monitored BRS indicators were significantly reduced in response to orthostatic stimulus. Such modulatory ability was not observed before implantation of the CRT device. Conclusions: The study confirmed the beneficial effect of the CRT on the autonomous nervous system function.
url https://www.atlantis-press.com/article/125930692/view
work_keys_str_mv AT annaprzybyla p811effectofcardiacresynchronisationtherapyontheautonomicnervoussystemfunction
AT danutaczarnecka p811effectofcardiacresynchronisationtherapyontheautonomicnervoussystemfunction
_version_ 1725103517854597120